IN VITRO AND IN VIVO EFFICACY OF COMBINATORIAL INHIBITION OF LSD1 AND HDACS IN PATIENT DERIVED GLIOBLASTOMA STEM CELL MODELS

被引：0
|
作者：
Gangadharan, Achintyan [1 ]
Grasse, Leslie [1 ]
Espejo, Alexsandra [1 ]
Ezhilarasan, Ravesanker [1 ]
Collier, Tiara [1 ]
Henry, Verlene [1 ]
Gumin, Joy [1 ]
Sulman, Erik [2 ]
Lang, Frederick [1 ]
Chandra, Joya [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] NYU Grossman Sch Med, Dept Radiat Oncol, New York, NY USA
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-75
引用
收藏
页码：103 / 104
页数：3
相关论文
共 50 条
  • [1] Inhibition of LSD1 and HDACs causes synergistic cell death in glioblastoma cells
    Singh, Melissa
    Manton, Christa
    Tsai, Wen-Wei
    Barton, Michelle
    Chandra, Joya
    [J]. CANCER RESEARCH, 2010, 70
  • [2] Evaluation of in vitro and in vivo efficacy of pharmacological lysine-specific demethylase 1 (LSD1) inhibitors in glioblastoma stem cell (GSC) models
    Stitzlein, Lea
    Gangadharan, Achintyan
    Grasse, Leslie
    Espejo, Alexsandra
    Singh, Melissa
    Lu, Yue
    Ezhilarasan, Ravesanker
    Gumin, Joy
    Sulman, Erik
    Lang, Frederick
    Chandra, Joya
    [J]. FASEB JOURNAL, 2022, 36
  • [3] Efficacy of EGFR/PI3K signaling inhibition is enhanced with LSD1 inhibition in glioblastoma stem cell (GSC) models
    Stitzlein, Lea
    Luetzen, Matthew
    McCabe, Caitlin
    Khosla, Maninder
    Singh, Melissa
    Su, Xiaoping
    Lu, Yue
    Gumin, Joy
    Lang, Frederick
    Whitehead, Christopher
    Sebolt-Leopold, Judith
    Chandra, Joya
    [J]. CANCER RESEARCH, 2022, 82 (12)
  • [4] Generation and characterization of a glioblastoma stem cell model with acquired resistance to LSD1 inhibition
    Patel, Kareena H.
    Stitzlein, Lea
    Nam, Deokhwa
    Lang, Frederick
    Gumin, Joy
    Chandra, Joya
    [J]. CANCER RESEARCH, 2024, 84 (06)
  • [5] Efficacy of LSD1 Directed Agents is Enhanced with Kinase Signaling Inhibition in Glioblastoma Stem Cells
    Stitzlein, Lea
    Adams, Jack
    Luetzen, Matthew
    Singh, Melissa
    Su, Xiaoping
    Lu, Yue
    Ezhilarasan, Ravesanker
    Gumin, Joy
    Lang, Frederick F.
    Sulman, Erik
    Chandra, Joya
    Monje-Deisseroth, Michelle
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2023, 385
  • [6] Syntheses of LSD1/HDAC Inhibitors with Demonstrated Efficacy against Colorectal Cancer: In Vitro and In Vivo Studies Including Patient-Derived Organoids
    Chou, Po-Yu
    Lai, Mei-Jung
    Tsai, Kelvin K.
    Cheng, Li-Hsin
    Wu, Yi-Wen
    Chen, Mei-Chuan
    Pan, Shiow-Lin
    Ho, Hsiu-O
    Nepali, Kunal
    Liou, Jing-Ping
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2024,
  • [7] In Vivo Effects of LSD1 Inhibition By Small Chemical Inhibitors in Sickle Cell Mice
    Le, Cuong
    Myers, Greggory
    Habara, Alawi
    Jearawiriyapaisarn, Natee
    Lee, Mary
    Chui, David H. K.
    Steinberg, Martin H.
    Engel, James
    Cui, Shuaiying
    [J]. BLOOD, 2017, 130
  • [8] LYSINE-SPECIFIC HISTONE DEMETHYLASE 1 (LSD1) CONTRIBUTES TO THE MAINTENANCE OF GLIOBLASTOMA STEM CELL POPULATION
    Faletti, S.
    Osti, D.
    Richichi, C.
    Marangoni, I.
    Ceccacci, E.
    Minucci, S.
    Pelicci, G.
    [J]. NEURO-ONCOLOGY, 2018, 20 : 300 - 300
  • [9] Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
    Stewart, C. Allison
    Byers, Lauren Averett
    [J]. CANCER CELL, 2015, 28 (01) : 4 - 6
  • [10] Pluripotent Stem Cell Protein Sox2 Confers Sensitivity to LSD1 Inhibition in Cancer Cells
    Zhang, Xiaoming
    Lu, Fei
    Wang, Jing
    Yin, Feng
    Xu, Zhengshuang
    Qi, Dandan
    Wu, Xianhui
    Cao, Yuwen
    Liang, Weihua
    Liu, Yuqing
    Sun, Hong
    Ye, Tao
    Zhang, Hui
    [J]. CELL REPORTS, 2013, 5 (02): : 445 - 457
12345